Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
Did you mean: (nivolumab)?
281 results
  • Budget impact model of avelumab in patients with metastatic merkel cell carcinoma in the US. [Journal Article]
  • COClinicoecon Outcomes Res 2019; 11:349-359
  • Bharmal M, Kearney M, … Phatak H
  • CONCLUSIONS: The model results indicate that the adoption of avelumab as a treatment option for mMCC would likely result in minimal budget impact from a US health plan perspective. Patients with mMCC, a rare condition with a poor prognosis and high unmet need, may benefit greatly from recently approved immunotherapies.
New Search Next